Astrazeneca Pharma India is currently trading at Rs. 1157.75, up by 91.90 points or 8.62% from its previous closing of Rs. 1065.85 on the BSE.
The scrip opened at Rs. 1135.10 and has touched a high and low of Rs. 1169.80 and Rs. 1124.90 respectively. So far 38116 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 1285.00 on 04-Mar-2014 and a 52 week low of Rs. 595.00 on 26-Mar-2013.
Last one week high and low of the scrip stood at Rs. 1169.80 and Rs. 1060.00 respectively. The current market cap of the company is Rs. 2895.00 crore.
The promoters holding in the company stood at 75.00% while Institutions and Non-Institutions held 15.96% and 9.04% respectively.
AstraZeneca Pharma India’s board will meet later this week to consider delisting the company from various bourses including the BSE and the National Stock Exchange. The board of directors of the company will meet on March 15 for the same.
Earlier this month, AstraZeneca Pharma had received by email a letter from AZP AB Sweden, promoter of the company, proposing to make a voluntary delisting offer to the public shareholders from BSE, NSE and Bangalore Stock Exchange.
Astrazeneca Pharmaceuticals AB holds 75 per cent in AstraZeneca Pharma India. AstraZeneca Pharma shares closed at Rs 1,065.85 apiece on the BSE, down 2.06 per cent. The company is engaged in the business of manufacturing and marketing pharmaceutical products in healthcare segments namely gastrointestinal, cardiovascular, cancer, respiratory, neurosciences and infection.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1797.80 |
Dr. Reddys Lab | 1213.90 |
Cipla | 1486.30 |
Lupin | 2069.95 |
Zydus Lifesciences | 948.70 |
View more.. |